Cara Therapeutics
CARA
$0.62
Share price
-6.08%
Change (1 day)
-58.90%
Change (1 year)
Categories
EPS for Cara Therapeutics (CARA)
EPS in 2023 (TTM): -$3.37
According to Cara Therapeutics 's latest financial reports the company's current EPS (TTM) is -$3.63. In 2022 the company made an earnings per share (EPS) of -$2.80 an increase over its 2021 EPS that were of -$3.04.
EPS history for Cara Therapeutics from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$3.37 | 20.38% |
| 2022 | -$2.80 | -8.09% |
| 2021 | -$3.04 | -1061.11% |
| 2020 | $0.32 | -107.23% |
| 2019 | -$4.38 | 20.87% |
| 2018 | -$3.63 | 7.85% |
| 2017 | -$3.36 | -9.05% |
| 2016 | -$3.70 | 110% |
| 2015 | -$1.76 | 17.65% |
| 2014 | -$1.50 | -3.42% |
| 2013 | -$1.55 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | -$7.88 | 117.48% | 🇺🇸 USA |
 | -$5.44 | 50.00% | 🇺🇸 USA |
 | $3.27 | -190.29% | 🇺🇸 USA |
 | $24.79 | -783.75% | 🇺🇸 USA |
 | -$17.21 | 374.64% | 🇺🇸 USA |